Defender experienced censorship on many social channels. Be sure to keep in touch with news that matters subscribe to our top news of the day. It’s free.
For the fifth time since the start of the COVID pandemic in early 2020, the rise in stock prices in Moderna made a billionaire.
President of Moderna Dr. Stephen Hoge is the latest shareholder and executive of the company to join the “three-comma-club”-with an estimated $ 1.1 billion in fortune.
Hoge, 45, joined Moderna in 2012 and owns 0.4% of Moderna’s stock – valued at $ 365 million – in addition to about $ 685 million of options. Like everyone else Moderna shareholders, Hoge regularly sells stock – including $ 65.5 million worth (pre -tax) between March 2020 and April 2021.
Activists say this generation of wealth is highlighting the severely unequal consequences from the pandemic, Reported by CNN.
“These billionaires are the human face of a lot of income strengthening Corporations are making from the monopoly they hold on these vaccines, ”said Anne Marriott, Oxfam’s health policy manager, in a statement. “These vaccines are funded with public money and should be first and foremost a benefit in the world, not a private revenue opportunity.”
From February 2020, The price on Moderna’s part earned more than 700%. Just last month, the company’s stock was up 29%. In this same timeframe, Moderna applied with Emergency Use Permit from the U.S. Food and Drug Administration for the COVID vaccine in adolescents, and increased the projected production of this vaccine in 2021, from 800 million doses to 1 billion.
Taxpayers pay the fee for vaccine research
As in The Defender reports previously, Moderna’s COVID vaccine funded almost all of the U.S. taxpayers. In partnership with the US government, Received by Moderna nearly $ 1 billion for its research and development mRNA vaccine, and up to $ 1.525 billion for the delivery of 100 million doses, with options for another 400 million.
Agreed to Citizenship, ang National Institutes of Health (NIH) owns the 50% stake in the Moderna mRNA vaccine, which the NIH has helped develop under the National Institute of Allergy and Infectious Diseases (NIAID), run by Anthony Fauci Dr..
As described in Human Vaccine, the US government gave millions in Moderna dollars back in 2013 to help improve mRNA technology. While the NIH is also developing new methods to target COVID spike proteins. When the coronavirus appeared in Wuhan, China, the NIH worked with Moderna to design and test a vaccine.
The U.S. Biomedical Advanced Research Development Authority gave Moderna an additional $ 483 million to further develop the vaccine and increase production.
Fauci and NIAID have a financial incentive to push Moderna’s vaccine over COVID vaccines to competitors – because Fauci personally, and other staff, have stake in finance of the Moderna vaccine. Fauci and four of his elected representatives depart hundreds of millions of dollars of royalties with Moderna from the sale of the vaccine.
Moderna continues to dismiss its vaccine problems
Moderna’s stock continues to rise, and its top executives have benefited though, despite increasing reports of injuries and deaths following the vaccine.
Agreed to most recent data from the Center for Disease Control and Prevention’s (CDC) Vaccine Adverse Events Reporting System (VAERS), between December 14, 2020 and June 4, a total of 329,021 total bad events reported following COVID vaccines, including 5,888 death and 28,441 severe report of damage.
As in The Defender reports this week, Simone Scott, a 19-year-old freshman at Northwestern University in Evanston, Ill., died June 11 of complications from a heart transplant he underwent after developing what his doctors thought was myocarditis after his second dose of the Moderna COVID vaccine.
Scott received his second dose of Modern on May 1, after which he developed heart complications that required him to undergo a heart transplant. He has doctors not fully confirmed the cause of his death, but they say Scott was suffering myocarditis – by aaccording to the researchers according to the National Organization for Rare Disorders, may be the result of infections, but “more often myocarditis results from the body’s immune reaction to initial heart damage.”
The Defender reports on June 15 that 21-year-old New Jersey student, Justin Harrington, suffered severe heart inflammation after receiving his second dose of the Moderna COVID vaccine.
Justin, whose school required him to get vaccinated to attend fall classes, experienced flu -like symptoms followed by heart disease within eight to 12 hours of receiving the vaccine.
“He had to wear a heart monitor and take four different medications in six months,” Justin’s father said. “He had to sleep soundly, couldn’t cope on his own and he lost one of the most important times of his life.”
As recently as last week, Moderna said this did not find a link between the COVID vaccine and cases of a rare inflammatory heart condition reported by young people who received shots.
The maker of the vaccine said in a statement this conclusion came after “careful examination available safety data to date for the Moderna COVID-19 vaccine for cases of myocarditis and / or pericarditis. ”
The CDC said on June 10 meetings of the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee the agency identified 226 reports of heart inflammation that could address the “working case definition” of myocarditis and pericarditis following bones, The Defender reports last week.
According to the CDC, a total 475 cases in myocarditis or pericarditis recorded in patients 30 and older received mRNA vaccine. The median age of people with myocarditis or pericarditis following the first dose was 30, and after the second dose, 24.
Modern SAYS it “will continue to monitor the vigilance of these reports and actively cooperate with public health and regulatory authorities to further investigate this issue.”
“We have a clear imbalance there,” Drs. Tom Shimabukuro of the CDC’s Immunization Safety Office on June 10 FDA meetings. The committee met to discuss safety issues regarding the use of COVID vaccines in children as young as 6 years of age.
The CDC has scheduled an emergency meeting of counselors on June 18 to discuss higher -than -expected reports of heart inflammation following doses of Pfizer and Moderna COVID vaccines.
I checked out the Modern vaccine
On May 10, EU regulators called Pfizer and Moderna in provide additional data related to companies ’COVID vaccines and a potential link to heart inflammation, after the agency completed a safety review of four COVID vaccines approved for emergency use in the EU.
In a report issued May 7, uncomfortable revealed that its members were aware of cases of myocarditis and pericarditis after Pfizer vaccination. Regulators said they saw no indication that the vaccine was causing these cases, but as a precaution, PRAC asked Pfizer to provide additional data, including an analysis of events based on age and gender. in the next pandemic safety report and will be considered if any more. control action is necessary.
Because Moderna and Pfizer use the same mRNA technology for their vaccines, the committee Moderna asked to monitor similar cases of heart inflammation.
MRNA vaccines are also involved in blood transfusions
A study released in April on Oxford University found the number of people developing CVST blood tumors after COVID vaccines was similar to Pfizer, Moderna and AstraZeneca, MarketWatch reported. (J&J was not approved for use in the EU, where the study began).